Skip to Content

Logo 2839 Logo 2839 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Actavis Pharma, Inc..

Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 2839 Logo 2839

Fenofibric acid delayed-release 135 mg Logo 2839 Logo 2839

Fenofibric Acid Delayed-Release

Imprint:
Logo 2839 Logo 2839
Strength:
135 mg
Color:
Brown & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00228-2839

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide